The October 22 report on Hoka noted signs that the running footwear brand’s multi-year growth is moderating. The firm also ...

BTIG analysts downgraded Deckers Outdoor (NYSE:DECK) from Buy to Neutral on Tuesday, citing signs of slowing growth across ...

The U.S. stock market is now approaching the end of what is typically the most volatile period of a presidential election ...

BTIG’s Jonathan Krinsky made a case that the S&P 500 utility sector may be poised for a downward correction. “We think it's ...

BTIG downgraded Deckers Outdoor (DECK) to Neutral from Buy without a price target The firm sees the stock’s risk/reward as balanced ...

BTIG raised the firm’s price target on MicroStrategy (MSTR) to $240 from $180 and keeps a Buy rating on the shares. The implied bitcoin ...

On Friday, BioNano Genomics Inc (BNGO) stock saw a modest uptick, ending the day at $0.33 which represents no change from the prior close of of $0.33. The stock opened at $0.33 and touched a low of $0 ...

BTIG analyst sees upside in Affirm stock to $68. The fintech is fully committed to soon becoming a profitable company.

Investors in exchange-traded funds tracking China stocks may be feeling some motion sickness after the country's stock market ...

BTIG Research reissued their buy rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note issued to investors on Friday morning, Marketbeat.com reports. BTIG Research currently has ...

In 2018 and 2019, Expedia and Booking tilted toward stock buybacks worth $15.8 billion while combined they spent just $335 ...

As of September 25, 2024, the average one-year price target for Apyx Medical is $3.57/share. The forecasts range from a low of $2.02 to a high of $6.30. The average price target represents an ...